University Hospital, Gentofte, Copenhagen: all 161 studies

Page 1 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.RecruitingNCT07893743Not applicable
• Effects of N-Acyl Taurines on Incretin Levels in Healthy SubjectsNot yet recruitingNCT07771166Not applicable
• Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansRecruitingNCT07506369Not applicable
• Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy IndividualsRecruitingNCT06934473Not applicable
• Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder ConditionsEnrolling by invitationNCT06435494Not applicable
• The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy IndividualsRecruitingNCT06419686Phase 1
• The Role of Oxytocin in Regulating Blood GlucoseRecruitingNCT06334172Not applicable
• The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial HypotensionEnrolling by invitationNCT06208904Not applicable
• Cohort of IPF Patients Experiencing an ExacerbationRecruitingNCT04442711
• Rehabilitation of Visual Function After Brain InjuryRecruitingNCT03160131Not applicable
• Insulin Sensitivity in Patients With Atopic DermatitisCompletedNCT03003793Results posted
• Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 DiabetesCompletedNCT00411411Phase 3Results posted
• The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00321321Phase 2Results posted
• Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide TreatmentCompletedNCT07171723Early Phase 1
• Separate and Combined Extrapancreatic Effects of GIP and GLP-1CompletedNCT06895408Not applicable
• The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 DiabetesCompletedNCT06881459Not applicable
• Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in ObesityActive, not recruitingNCT06845033Not applicable
• Understanding How Gut and Brain Barriers Are Linked to Inflammation in ObesityCompletedNCT06787001
• Serum Metabolics-based Method for Diagnosing Bile Acid DiarrhoeaCompletedNCT06548009
• Investigating Glucose Metabolism of LEAP2 With Total-body PET/CTActive, not recruitingNCT06254365Not applicable
• The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with ObesityCompletedNCT06189001Not applicable
• Neuronostatin - a Glucagonotropic Agent in Humans?CompletedNCT06143267Not applicable
• The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 DiabetesCompletedNCT06137586Not applicable
• Incretin Effect in Patients With Psoriasis and ControlsCompletedNCT06064084
• Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred ConsultationsActive, not recruitingNCT06032403Not applicable
• The Glucagonotropic Effect of Amino Acids in HumansCompletedNCT05954923Not applicable
• Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male SubjectsCompletedNCT05953064Not applicable
• Dapiglutide for the Treatment of ObesityActive, not recruitingNCT05788601Phase 2
• Do Patients With Fish or Shellfish Allergy Tolerate the Consumption of Fish Oil Supplements? A Clinical StudyCompletedNCT05677074Not applicable
• The Relationship Between Inflammatory ARTritis and CArdiac DIseAseActive, not recruitingNCT05647577
• LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese MalesStatus unknownNCT05603598Not applicable
• A Glucometabolic Evaluation of Patients With Idiopathic Ketotic HypoglycemiaActive, not recruitingNCT05310292Not applicable
• Separate and Combined Extrapancreatic Effects of the Incretin HormonesCompletedNCT05177653Not applicable
• InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza InfectionCompletedNCT05084846
• The Role of the Kidneys and Liver in the Elimination of GlucagonCompletedNCT05056584Not applicable
• LEAP2 Kinetics in Healthy IndividualsCompletedNCT04897984Early Phase 1
• Drug Allergy Labels After Drug Allergy InvestigationCompletedNCT04827602
• Physiology of GIP(1-30)NH2 in HumansCompletedNCT04792762Not applicable
• The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder EmptyingCompletedNCT04651868Not applicable
• LEAP2 on Postprandial Glucose Metabolism and Food IntakeCompletedNCT04621409Early Phase 1
• Outpatient Follow-up on Demand in Rheumatoid ArthritisCompletedNCT04476875Not applicable
• The Malaria Heart Disease StudyTerminatedNCT04445103
• The Role of Ultrasound in COVID-19CompletedNCT04377035
• Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19CompletedNCT04351581Not applicable
• The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin ResistanceTerminatedNCT04315350Not applicable
• The Physiological Effects of FGF21 on Alcohol Preference and Glucose MetabolismCompletedNCT04232033Not applicable
• Metabolic Effects of One-weak Heavy DrinkingCompletedNCT04229550Not applicable
• The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 DiabetesCompletedNCT04228484Not applicable
• The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes MellitusCompletedNCT04108065
• The Effect of Insulin-induced Hypoglycaemia on Gut-derived Glucagon Secretion (Px-Hypo)CompletedNCT04064203Not applicable
• Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon SecretionCompletedNCT04061473Not applicable
• Bariatric Surgery on NASHCompletedNCT04043585
• Liver-enriched Antimicrobial Peptide 2CompletedNCT04043065Early Phase 1
• Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric BypassCompletedNCT03984370Phase 2
• Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?CompletedNCT03954873Not applicable
• FGF21 and Its Role in Alcohol DependenceCompletedNCT03892369Not applicable
• Mind-Body Approaches for Medical ConditionsStatus unknownNCT03888261Not applicable
• GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic PolypeptideCompletedNCT03845179Not applicable
• Radiofrequency vs Cryoballoon Ablation for Atrial Fibrillation Assessed by Implantable Cardiac MonitorCompletedNCT03805555Not applicable
• The Effect of GIP(3-30)NH2CompletedNCT03770910Not applicable
• Effect of GIP After a Meal in Patients With Type 2 DiabetesCompletedNCT03702660Not applicable
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food IntakeCompletedNCT03526289Not applicable
• Medial Unicondylar Knee Arthroplasty vs Total Knee ArthroplastyActive, not recruitingNCT03396640Not applicable
• Investigation of Acute Physiological Effects of Aspiration TherapyCompletedNCT03389269
• The Influence of Cholecystectomy on Secretion of Incretin HormonesCompletedNCT03305783
• The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2DCompletedNCT03246451Not applicable
• Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNCT03241303Not applicable
• The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon SecretionCompletedNCT03181191Not applicable
• Hypoglycaemia and Cardiac Arrhythmias in Type 2 DiabetesCompletedNCT03150030
• Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single BolusCompletedNCT03142789Phase 4
• Inhibition of the Endogenous GIP Response With a GIP Receptor AntagonistCompletedNCT03133741Not applicable
• Nutritional Intervention in Geriatric PatientsCompletedNCT03131856Not applicable
• The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without SulphonylureaCompletedNCT03081676Not applicable
• Anatomical and Physiological Characterisation of the Gut Endocrine Cells in Healthy and in Patients With Type 2 DiabetesCompletedNCT03044860Not applicable
• The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionCompletedNCT03018444Not applicable
• Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)CompletedNCT03013296Not applicable
• Bileacid Malabsorption and GLP-1 SecretionCompletedNCT03009916Phase 4
• COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPDCompletedNCT02987439Not applicable
• Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With PsoriasisCompletedNCT02978001
• Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor AntagonismStatus unknownNCT02944110Not applicable
• Effect of PROGRESSive Training and Teststerone in Older Frail MenCompletedNCT02873559Phase 2/3
• The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 InhibitorsCompletedNCT02792400Not applicable
• GIP Receptor Antagonist Studies in HumansCompletedNCT02747472Not applicable
• Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 DiabetesCompletedNCT02669524Not applicable
• The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised SubjectsCompletedNCT02640118Not applicable
• GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food IntakeCompletedNCT02598791Not applicable
• Shared Care for Patients With Type 2 Diabetes Across the Primary and Secondary Health Care SectorCompletedNCT02586545Not applicable
• Effect of Smoking on Postprandial Gastric Emptying, Glucose Tolerance and Secretion of Gut and Pancreatic HormonesCompletedNCT02497651Not applicable
• Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 DiabetesCompletedNCT02497313Not applicable
• Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon ClearanceCompletedNCT02475421Not applicable
• Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompletedNCT02445508Not applicable
• A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With PsoriasisCompletedNCT02382081Not applicable
• Involvement of Steatosis-induced Glucagon Resistance in HyperglucagonaemiaCompletedNCT02337660Not applicable
• Life Without DiabetesCompletedNCT02212665Not applicable
• Correlation Between Plasma- and Endothelial DPP-4 ActivityCompletedNCT02192853Phase 4
• Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut MicrobiotaCompletedNCT02061124Not applicable
• The Role of Metformin and Colesevelam in Human GLP-1 SecretionCompletedNCT02050074Phase 4
• Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With PsoriasisTerminatedNCT02047851Not applicable
• Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose InfusionCompletedNCT02010827
• Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose DisposalCompletedNCT02006459

← University Hospital, Gentofte, Copenhagen overview and focus areas